Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > NaturalNano's Report on the Capture and Manipulation of Circulating Cancer Cells to Be Presented in Venice, Italy

Abstract:
NaturalNano, Inc. (OTCBB: NNAN) (www.naturalnano.com) announced yesterday that Dr. Michael King of Cornell University will present their recent work at the First NEMB Venice Workshop on Cancer Nanotechnology in Venice, Italy. (nemb2012.cism.it)

NaturalNano's Report on the Capture and Manipulation of Circulating Cancer Cells to Be Presented in Venice, Italy

Rochester, NY | Posted on October 13th, 2012

This Nanobiotechnology presentation will demonstrate that the capture of circulating tumor cells (CTCs) in blood can be targeted more effectively by the incorporation of NaturalNano's Halloysite Natural Tubes (HNT) onto the surface of devices. These devices are used to capture circulating tumor cells (CTCs) in blood. King's Lab has developing new methods for the isolation of intact, viable cancer cells from patient blood, based on the physiological adhesion of selectin proteins in micro-scale flow devices. Watch Video www.jove.com/video/4248

This Nanobiotechnology presentation will demonstrate that the capture of circulating tumor cells (CTCs) in blood can be targeted more effectively by the incorporation of NaturalNano's Halloysite Natural Tubes (HNT) onto the surface of devices. These devices are used to capture circulating tumor cells (CTCs) in blood. King's Lab has developing new methods for the isolation of intact, viable cancer cells from patient blood, based on the physiological adhesion of selectin proteins in micro-scale flow devices. Watch Video http://www.jove.com/video/4248

Dr. King, an Associate Professor of biomedical engineering at Cornell University, states, "The ability to create stable coatings of Halloysite nanotubes (HNT) using an extremely thin layer of poly-L-lysine allows the creation of nanostructured surfaces to which living cells respond. The microtubes with HNT incorporated onto their surface were found to enhance the natural CTC rolling mechanism. This allows the cells to be exposed to specific therapeutic agents or isolated and collected for diagnostic and research purposes."

James Wemett, NaturalNano CEO, said, "We are pleased to have our HNT technology used in Dr. King's important work be presented on a global platform. The use of HNT in a medical application is a new area of application for NNAN and we hope that Dr. King's work continues to advance."

NaturalNano, Inc. (OTCBB: NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. www.naturalnano.com

Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.

####

For more information, please click here

Contacts:
Jim Wemett
NaturalNano, Inc.
585-267-4848


Tom Morabito
Park Avenue Investor Relations
585-586-7786

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Videos/Movies

Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014

Director Wally Pfister joins UC Berkeley neuroengineers to discuss the science behind ‘Transcendence’ April 7th, 2014

KEEP CALM and PUBLISH PAPERS – a new video blog with graphic tutorials to scientific publishing April 7th, 2014

Nanomedicine

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

Announcements

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Events/Classes

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014

Engineers develop new materials for hydrogen storage April 15th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE